Focus: iota Biosciences develops implantable bioelectronic devices targeting gastroenterology, neurology, and ophthalmology indications. The company is an early-stage medical device player founded in 2017, based in Alameda, CA.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Cooling — net -6 jobs in 30d
2 added, 8 removed. Slower than typical.
iota Biosciences is a speculative early-stage bioelectronics play best suited for risk-tolerant professionals seeking equity upside and core technical influence, not stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for iota Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from iota Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub